SOURCE-LINKED STUDY SUMMARY
Mitochondrial homeostasis in musculoskeletal diseases: From pathogenic mechanisms to precision therapies.
Abstract summarizedQuality not appraised
- What was studied
- A review of mitochondrial dysfunction and potential targeted treatments in musculoskeletal disease.
- Who / model studied
- Preclinical and clinical research on bone, cartilage and muscle, especially osteoporosis, osteoarthritis and rheumatoid arthritis. This was a review, not a newly enrolled cohort.
- Studied dose & schedule
- Dose and schedule were not reported in the source used for this summary.
- What the study found
- The review links impaired energy production, mitochondrial maintenance and oxidative balance with disease mechanisms. It discusses candidate approaches including MitoQ, metformin, NAD+ boosters and urolithin A.
- Limitations & context
- The abstract proposes a treatment framework but reports no new comparative trial or compound-specific effect sizes. The discussed approaches remain a research landscape, not established benefits for every condition.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1016/j.phrs.2026.108441